A Phase 1 Study of CDX-1140, a Fully Human Agonist Anti-CD40 Monoclonal Antibody
- This topic has 0 replies, 1 voice, and was last updated 4 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A Phase 1 Study of CDX-1140, a Fully Human Agonist Anti-CD40 Monoclonal Antibody, in Patients With Advanced Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT03329950
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.